An anti-mesothelin targeting antibody drug conjugate induces pyroptosis and ignites antitumor immunity in mouse models of cancer.
Nicole L WittwerAlexander H StaudacherVasilios LiapisPina CardarelliHarriet WarrenMichael P BrownPublished in: Journal for immunotherapy of cancer (2023)
Together, these results show for the first time that tubulysin and a tubulysin containing ADC can elicit pyroptosis, and that this fiery cell death is critical for antitumor immunity and therapeutic response.